Sino Biopharmaceutical Limited
SBMFF
$0.9891
$0.03914.12%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 130.16% | 95.88% | 68.09% | -1.51% | -50.03% |
| Total Depreciation and Amortization | -22.32% | -44.16% | -57.21% | -46.77% | -33.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -155.15% | -132.97% | -122.92% | -92.76% | -72.39% |
| Change in Net Operating Assets | -- | -- | -- | -- | -- |
| Cash from Operations | 10.67% | -18.10% | -36.24% | -47.94% | -56.84% |
| Capital Expenditure | 48.10% | 61.62% | 70.09% | 55.00% | 38.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -2.39% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 12.02% | -61.93% | -758.96% | -105.87% | -20.61% |
| Cash from Investing | 51.90% | 33.63% | -11.15% | -3.74% | 0.47% |
| Total Debt Issued | -38.57% | -43.80% | -48.21% | -22.34% | 12.03% |
| Total Debt Repaid | 32.25% | 33.85% | 35.37% | 0.27% | -57.79% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -53.39% | -36.51% | -22.98% | 48.58% | 72.83% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -22.11% | 39.61% | 59.89% | 58.69% | 57.14% |
| Cash from Financing | 2.61% | 17.93% | 29.91% | 9.37% | -28.91% |
| Foreign Exchange rate Adjustments | -70.27% | -79.60% | -84.75% | -48.64% | 86.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.63% | 27.42% | -13.11% | -130.91% | -438.42% |